Decreased TMEM40 expression is associated with malignant behavior of cutaneous squamous cell carcinoma and inhibits

Lei Yu1, Jie Liu2, Tang-De Zhang1

  • 1Department of Dermatology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510282, P.R. China.

Oncology Letters
|June 30, 2021
PubMed

Insights

Transmembrane protein 40 (TMEM40) is elevated in cutaneous squamous cell carcinoma (CSCC). Reducing TMEM40 inhibits CSCC cell growth, migration, and invasion, suggesting it

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Cutaneous squamous cell carcinoma (CSCC) is a prevalent human skin cancer.
  • Understanding cancer-associated transmembrane proteins is crucial for CSCC molecular biology.
  • Transmembrane protein 40 (TMEM40) role in CSCC requires investigation.

Purpose of the Study:

  • To evaluate TMEM40 expression patterns in CSCC.
  • To determine the clinical significance of TMEM40 in CSCC.
  • To elucidate the underlying mechanisms of TMEM40 in CSCC progression.

Main Methods:

  • Quantitative PCR, Western blot, and immunohistochemistry for TMEM40 expression analysis.
  • Cell Counting Kit-8 assays for proliferation assessment.
  • Wound healing, flow cytometry, and Transwell assays for migration, cell cycle, apoptosis, and invasion studies.

Main Results:

  • TMEM40 expression is significantly increased in CSCC tissues compared to normal skin.
  • Elevated TMEM40 expression correlates with larger tumor size in CSCC patients.
  • TMEM40 silencing in CSCC cells induced G0/G1 cell cycle arrest, promoted apoptosis, and inhibited migration and invasion.

Conclusions:

  • TMEM40 plays a role in regulating CSCC cell growth, cell cycle, apoptosis, migration, and invasion.
  • Reduced TMEM40 expression inhibits CSCC development.
  • TMEM40 represents a potential therapeutic target for CSCC treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K